Research Fellow, Doctoral Advisor, DCST
Nearly 20 years of toxicology research experience
NMPA new drug evaluation expert
Member of NMPA CDE Expert Groups for Biosimilar and Cell Therapy Guidances; Member of NMPA CDE ICH S9 Expert Group
Deputy Secretary-General of the Toxicology on Traditional Chinese Medicine and Natural Medicine Specialty Section,Chinese Society of Toxicology; Committee member of the Drug Safety Evaluation and Research Specialty Section, Chinese Pharmaceutical Association.

Certified CPA. Fifteen years of experience in financial management within the pharmaceutical field. Able to provide insight for the management decision making from a financial perspective.

Ph.D., Doctoral Advisor, DCST 

•Member of the Standing Committee on Toxicology and Safety Evaluation of Biotech Drugs, Chinese Society of Toxicology

•Member of the Standing Committee on Safety Pharmacology, Chinese Society of Pharmacology

•Author of over 70 SCI-indexed publications

•17+ years of experience in toxicology research